<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
66406-0203-0
</NDCCode>
<PackageDescription>
28571 TABLET in 1 CONTAINER (66406-0203-0)
</PackageDescription>
<NDC11Code>
66406-0203-00
</NDC11Code>
<ProductNDC>
66406-0203
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Eslicarbazepine Acetate
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20140407
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Patheon Inc.
</LabelerName>
<SubstanceName>
ESLICARBAZEPINE ACETATE
</SubstanceName>
<StrengthNumber>
600
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2021-12-21
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20221231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
07-APR-14
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>